Search

Author/Creator Slasor, Peter

2. Clinical Pharmacokinetics and Pharmacodynamics of Cerliponase Alfa, Enzyme Replacement Therapy for CLN2 Disease by Intracerebroventricular Administration. Issue 2 (30th November 2020)

Authors:
Kim, Aryun; Grover, Anita; Hammon, Kevin; de Hart, Greg; Slasor, Peter; Cherukuri, Anu; Ajayi, Temitayo; Jacoby, David; Schulz, Angela; Specchio, Nicola; de Los Reyes, Emily; Gissen, Paul; Henshaw, Joshua W.
Journal:
Clinical and translational science
Issue:
Volume 14:Issue 2(2021)
Page Start:
635
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Disease characteristics and progression in patients with late-infantile neuronal ceroid lipofuscinosis type 2 (CLN2) disease: an observational cohort study. (August 2018)

Authors:
Nickel, Miriam; Simonati, Alessandro; Jacoby, David; Lezius, Susanne; Kilian, Dirk; Van de Graaf, Benjamin; Pagovich, Odelya E; Kosofsky, Barry; Yohay, Kaleb; Downs, Matthew; Slasor, Peter; Aiayi, Temitayo; Crystal, Ronald G; Kohlschütter, Alfried; Sondhi, Dolan; Schulz, Angela
Journal:
Lancet
Issue:
Volume 2:Number 8(2018)
Page Start:
582
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Disease characteristics and progression in patients with late-infantile neuronal ceroid lipofuscinosis type 2 (CLN2) disease: an observational cohort study. (August 2018)

Authors:
Nickel, Miriam; Simonati, Alessandro; Jacoby, David; Lezius, Susanne; Kilian, Dirk; Van de Graaf, Benjamin; Pagovich, Odelya E; Kosofsky, Barry; Yohay, Kaleb; Downs, Matthew; Slasor, Peter; Ajayi, Temitayo; Crystal, Ronald G; Kohlschütter, Alfried; Sondhi, Dolan; Schulz, Angela
Journal:
Lancet
Issue:
Volume 2:Number 8(2018)
Page Start:
582
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Efficacy and safety of enzyme replacement therapy with BMN 110 (elosulfase alfa) for Morquio A syndrome (mucopolysaccharidosis IVA): a phase 3 randomised placebo‐controlled study. Issue 6 (9th May 2014)

Authors:
Hendriksz, Christian J.; Burton, Barbara; Fleming, Thomas R.; Harmatz, Paul; Hughes, Derralynn; Jones, Simon A.; Lin, Shuan‐Pei; Mengel, Eugen; Scarpa, Maurizio; Valayannopoulos, Vassili; Giugliani, Roberto; Slasor, Peter; Lounsbury, Debra; Dummer, Wolfgang
Journal:
Journal of inherited metabolic disease
Issue:
Volume 37:Issue 6(2014)
Page Start:
979
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗